Your browser doesn't support javascript.
loading
Hypofractionated Stereotactic Re-irradiation and Anti-PDL1 Durvalumab Combination in Recurrent Glioblastoma: STERIMGLI Phase I Results.
Pouessel, Damien; Ken, Soléakhéna; Gouaze-Andersson, Valérie; Piram, Lucie; Mervoyer, Augustin; Larrieu-Ciron, Delphine; Cabarrou, Bastien; Lusque, Amélie; Robert, Marie; Frenel, Jean-Sebastien; Uro-Coste, Emmanuelle; Olivier, Pascale; Mounier, Muriel; Sabatini, Umberto; Sanchez, Eduardo Hugo; Zouitine, Mehdi; Berjaoui, Ahmad; Cohen-Jonathan Moyal, Elizabeth.
Afiliación
  • Pouessel D; Department of Medical Oncology, Institut Universitaire du Cancer Toulouse Oncopole, Institut Claudius Re-gaud, Toulouse, France.
  • Ken S; Department of Engineering and Medical Physics, Institut Universitaire du Cancer Toulouse Oncopole, Institut Claudius Regaud, Toulouse, France.
  • Gouaze-Andersson V; INSERM UMR1037, Centre de Recherche en Cancérologie de Toulouse (CRCT), Team Radiation Optimization "RADOPT", Toulouse, France.
  • Piram L; INSERM UMR1037, Centre de Recherche en Cancérologie de Toulouse (CRCT), Team Radiation Optimization "RADOPT", Toulouse, France.
  • Mervoyer A; Department of Radiation Oncology, Institut Universitaire du Cancer Toulouse Oncopole, Institut Claudius Regaud, Toulouse, France.
  • Larrieu-Ciron D; INSERM UMR1037, Centre de Recherche en Cancérologie de Toulouse (CRCT), Team Radiation Optimization "RADOPT", Toulouse, France.
  • Cabarrou B; Department of Radiation Oncology, Institut Universitaire du Cancer Toulouse Oncopole, Institut Claudius Regaud, Toulouse, France.
  • Lusque A; Department of Radiation Oncology, Institut de Cancérologie de l'Ouest, Nantes, France.
  • Robert M; Department of Medical Oncology, Institut Universitaire du Cancer Toulouse Oncopole, Institut Claudius Re-gaud, Toulouse, France.
  • Frenel JS; Department of Biostatistics, Institut Universitaire du Cancer Toulouse Oncopole, Institut Claudius Regaud, Toulouse, France.
  • Uro-Coste E; Department of Biostatistics, Institut Universitaire du Cancer Toulouse Oncopole, Institut Claudius Regaud, Toulouse, France.
  • Olivier P; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Nantes, France.
  • Mounier M; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Nantes, France.
  • Sabatini U; INSERM UMR1037, Centre de Recherche en Cancérologie de Toulouse (CRCT), Team Radiation Optimization "RADOPT", Toulouse, France.
  • Sanchez EH; Department of Anatomopathology, CHU Toulouse, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France.
  • Zouitine M; Department of Medical and Clinical Pharmacology, Center of Pharmacovigilance and Pharmacoepidemiology, Toulouse University Hospital, Toulouse, France.
  • Berjaoui A; Clinical Research Unit, Institut Universitaire du Cancer Toulouse Oncopole, Institut Claudius Regaud, Toulouse, France.
  • Cohen-Jonathan Moyal E; Institute of Neuroradiology, University Magna Graecia, Catanzaro, Italy.
Oncologist ; 28(9): 825-e817, 2023 09 07.
Article en En | MEDLINE | ID: mdl-37196069
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Radiocirugia / Glioblastoma / Reirradiación Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Radiocirugia / Glioblastoma / Reirradiación Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Reino Unido